AUCMA Co.,Ltd.: history, ownership, mission, how it works & makes money

From a Qingdao factory founded in 1987 to a publicly traded industrial player under ticker 600336.SS since December 2000, AUCMA Co., Ltd. has evolved into a vertically integrated refrigeration and cold-chain specialist-notably developing China's first independently made -86℃ ultra-low temperature freezer in 2004, becoming a WHO-qualified medical cold-chain supplier by 2010, opening a national industrial design center in 2015 and launching the ARKTEK passive vaccine storage box in 2021-while its ownership remains anchored by state-owned Qingdao Aucma Holding Group and Qingdao Enterprise Development Investment, with Qingdao Chengtou Chengjin holding 4.2356% after a 0.8786% reduction in February 2025; operating through R&D, intelligent manufacturing and global sales to over 100 countries, AUCMA earned CNY 7,816.07 million in sales in 2024 (down from CNY 9,303.77 million in 2023), invests about 5% of revenue in R&D, offers a 5-year warranty and reports a 92% customer satisfaction rate as it pushes for a 30% reduction in product energy consumption by 2025 while divesting non-core assets and expanding smart appliance and international revenue streams

AUCMA Co.,Ltd. (600336.SS): Intro

• Founded 1987 as Qingdao Hongxing Electric General Factory, specializing in refrigeration equipment manufacturing.
• Listed on the Shanghai Stock Exchange (600336.SS) in December 2000.
• 2004: delivered China's first independently developed -86℃ ultra-low temperature freezer.
• By 2010: expanded into medical cold chain and became a qualified supplier for the World Health Organization (WHO).
• 2015: established a national industrial design center to strengthen product R&D and industrial design capabilities.
• 2021: launched ARKTEK passive vaccine storage box addressing vaccine transport and storage challenges globally.

• Listed public company on SSE (Ticker: 600336.SS) with a mix of state-owned, institutional, and retail shareholders typical for Chinese appliance groups.
• Major shareholders historically include local state-owned investment vehicles and founding management; free float enables institutional investor participation.
• Group structure comprises core manufacturing and R&D subsidiaries focused on household refrigeration, medical cold chain, engineering insulation, and international sales.

• Mission: deliver safe, reliable cold-chain and refrigeration solutions that protect health and food through innovation and quality manufacturing.
• Vision: be a global cold-chain technology leader combining household appliance heritage with specialized medical-grade refrigeration and passive storage systems.
• Capabilities emphasized: vertical manufacturing, industrial design, low-temperature R&D, and regulatory compliance for medical products.

• R&D and product design: in-house industrial design center and specialist low-temperature labs (e.g., -86℃ development capability).
• Manufacturing: vertically integrated production for compressors, cabinets, insulation and temperature-control systems across household and medical ranges.
• Quality & regulatory: medical cold-chain lines designed to meet WHO and other international procurement standards.
• Sales & distribution: domestic retail/home appliance channels, institutional procurement (hospitals, immunization programs), and export markets aided by passive solutions (ARKTEK).
• After-sales and service: warranty, maintenance, and calibration services for medical/ultra-low temperature equipment-critical for recurring institutional revenue.

• Household appliances: refrigerators/freezers sold via retail and dealer networks-volume-driven, seasonal, and promotional sales.
• Medical cold chain equipment: high-margin, specification-driven sales to hospitals, laboratories, vaccine programs, and international agencies.
• Specialized products & solutions: ultra-low temperature freezers, vaccine passive storage (ARKTEK), and integrated cold-chain systems for logistics providers.
• Components & OEM: compressors, insulation modules and components supplied to third parties or used internally-contributes to gross margin stability.
• Service & maintenance contracts: calibration, maintenance, and parts-provides recurring service revenue and customer lock-in.

• Longstanding manufacturing base and experience in refrigeration technologies since 1987.
• Proven ultra-low temperature R&D (-86℃ capability) and WHO-qualified medical cold-chain products.
• Vertical integration of components and assembly, improving cost control and supply resilience.
• Design and innovation capability bolstered by a national industrial design center (est. 2015).

• Commodity and input-cost volatility (compressors, refrigerants, steel).
• Competitive pressure from domestic appliance giants and specialized medical cold-chain suppliers.
• Regulatory and export compliance for medical devices and vaccine storage solutions.

AUCMA Co.,Ltd. (600336.SS): History

• State-linked roots: key shareholders are municipal/state-owned enterprises based in Qingdao, shaping long-term industrial strategy.
• Product evolution: legacy consumer refrigeration business complemented by medical cold-chain and industrial compressors.
• Capital markets: listed on the Shanghai Stock Exchange (600336.SS), enabling wider investor participation and financing for R&D and capacity expansion.

• As of late 2025, Qingdao Aucma Holding Group Co., Ltd. (state-owned) is the largest shareholder, holding a substantial stake.
• Qingdao Enterprise Development Investment Co., Ltd. (state-owned) is the second-largest shareholder, reflecting strong state involvement.
• In February 2025, Qingdao Chengtou Chengjin reduced its holdings by 0.8786%, retaining a 4.2356% stake in AUCMA.
• Shares trade on the Shanghai Stock Exchange with a mixed base of institutional and retail investors; state-owned major shareholders materially influence strategic direction.
• State backing has facilitated access to government resources and support for technological upgrades and market expansion.

• Alignment with national and municipal industrial policies guides investments in medical cold-chain, energy-efficient appliances, and smart manufacturing.
• State shareholders facilitate access to government procurement, subsidies, and favorable financing-supporting R&D and capacity upgrades.
• Board and senior management selection reflect shareholder composition, leading to longer-term, policy-aligned decision-making.

AUCMA Co.,Ltd. (600336.SS): Ownership Structure

• Mission: To be the most reliable refrigeration equipment supplier and expert globally, focused on innovation and quality.
• Values: technological advancement, sustainability, customer satisfaction, integrity and continuous improvement.
• R&D commitment: ~5% of annual revenue invested in research and development.

• Sustainability target: reduce energy consumption by 30% across product lines by 2025.
• Customer support: 5-year warranty on major appliances; reported 92% customer satisfaction rate.
• Product milestone: developed China's first -86℃ ultra-low temperature freezer (2004).

• How it makes money: core revenue from refrigeration and household appliance sales (commercial and consumer refrigerators, freezers, integrated kitchen appliances), OEM/ODM manufacturing, after-sales service and extended warranty programs, and specialized medical/ultra-low temperature equipment for research and healthcare.
• Business model drivers: product innovation (cold chain & ultra-low temp), energy-efficient product lines, channel mix across domestic retail, e-commerce and B2B/government procurement, plus service and parts margins.

AUCMA Co.,Ltd. (600336.SS): Mission and Values

• End-to-end integration: in-house design → components sourcing → assembly → distribution → after-sales.
• R&D strength: national industrial design center and a key laboratory focused on low-temperature refrigeration technologies drive product differentiation and regulatory compliance for medical cold chain products.
• Intelligent manufacturing: automated production lines and MES/ERP systems increase throughput and reduce defect rates.

• National industrial design center: central role in conceptual and industrial design for consumer and specialized refrigeration units.
• Key laboratory for low-temperature refrigeration: supports vaccine/biomedical cold-chain units with temperature stability testing down to -80°C for certain product families.
• R&D staffing and investment: company historically allocates roughly 3-5% of revenue to R&D annually and maintains several hundred R&D engineers (company disclosures typically report 300-800 R&D personnel depending on year and scope).

• Export footprint: products sold to over 100 countries and regions, covering ASEAN, MENA, Africa, Latin America and parts of Europe.
• Channel mix: combination of domestic retail, branded stores, B2B commercial contracts (cold chain, medical) and export distributors.
• Strategic partnerships: collaborations with international organizations-including supply of medical cold-chain equipment for WHO-led initiatives-underscore credentials for regulated medical refrigeration.

• Annual revenue: in recent fiscal years typically in the multi-billion RMB range (company reports historically range across RMB several billion depending on market cycles).
• Profitability: net profit margins fluctuate by year and segment; commercial/medical refrigeration often yields higher margins than commodity consumer lines.
• CapEx and investment: sustained capital investment in plant automation and R&D to support intelligent manufacturing and cold-chain certification.
• Workforce: several thousand employees across R&D, manufacturing, sales and after-sales operations.

• 5-year warranty on major appliances bolsters brand trust and reduces churn.
• Service coverage: nationwide service network in China and local partners overseas to maintain equipment uptime-critical for medical cold chain clients.
• Customer satisfaction: company-reported ~92% satisfaction rate reflecting service responsiveness and product reliability.

AUCMA Co.,Ltd. (600336.SS): How It Works

• Core product lines: household refrigerators, commercial freezers, medical cold chain equipment, and smart-home appliances.
• Sales channels: domestic OEM/retail, direct dealer networks, B2B commercial sales (cold chain & foodservice), and export to over 100 countries and regions.
• Monetization levers: unit sales, premium/energy-efficient product pricing, extended warranties & service, component sales, and software/features for smart appliances.

• Household refrigerators: ~55% - CNY 4,298.84 million
• Commercial freezers (foodservice/retail): ~20% - CNY 1,563.21 million
• Medical cold chain & specialized refrigeration: ~10% - CNY 781.61 million
• Smart-home appliances and connected features: ~15% - CNY 1,172.41 million

• Product diversification: expanding from traditional refrigeration into smart appliances to capture higher-margin connected services.
• Energy-efficiency focus: energy-efficient models support competitive pricing and regulatory/commercial incentives, aiding unit demand.
• Global expansion: exports to over 100 countries broaden the revenue base and partially hedge domestic market fluctuations.
• R&D allocation: approximately 5% of annual revenue invested in innovation to improve efficiency, refrigeration technology, and smart features.
• Cost and pricing strategy: competitive pricing on commodity appliances while targeting premium pricing for energy-efficient and medical cold-chain solutions.

AUCMA Co.,Ltd. (600336.SS): How It Makes Money

• Sales of commercial and household refrigeration units (freezers, refrigerators, display cabinets) - the largest revenue contributor by volume and value.
• Sales of major household appliances and smart-home devices (water heaters, air-conditioners, small appliances), bundled with after-sales service contracts.
• OEM/ODM manufacturing for domestic and international appliance brands, leveraging large-scale production capacity.
• Spare parts, consumables and extended warranty/service plans that provide higher-margin recurring income.
• Export sales to overseas distributors and retailers across more than 100 countries and regions, contributing diversification and foreign-currency revenue.

• Leading Chinese refrigeration manufacturer with significant installed base in retail and cold-chain segments, anchoring recurring replacement and service demand.
• Facing intensified competition from domestic rivals and import players, which has driven recent declines in sales and net profit (see table).
• Pursuing asset optimization and divestment of non-core operations to concentrate investment, R&D and manufacturing capacity on refrigeration and smart home appliances.
• Doubling down on innovation and quality controls-investing in energy-efficient compressors, smart controls and modular designs aimed at regaining margin and market share.
• Expanding international distribution and aftermarket services to stabilize revenue streams and exploit higher-margin export channels.

• Scale manufacturing to lower unit cost (bulk procurement, automated lines) while retaining flexibility for OEM/ODM partners.
• Product mix management - shifting toward higher-margin smart appliances and service contracts.
• Cost controls via asset optimization and pruning of non-core business units to improve return on assets and cash flow.
• Sustainability-driven product upgrades to meet regulatory and retailer requirements, with the 30% energy reduction target by 2025 aimed at both market differentiation and compliance.